Profusa, Provides Strategy Overview and Business Update for Investors
Profusa, a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, provides a strategy overview and business update from Chairman and CEO, Ben Hwang, Ph.D. in the following Letter to Shareholders: To our valued shareholders, In the last two......